Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases

被引:0
|
作者
Jing Wang
Zhiyan Liu
Qingsong Pang
Tian Zhang
Xi Chen
Puchun Er
Yuwen Wang
Ping Wang
Jun Wang
机构
[1] Tianjin’s Clinical Research Centre for Cancer,Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cance
来源
BMC Cancer | / 20卷
关键词
Non-small cell lung cancer; Brain metastasis; mutation; Prognosis; Treatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Survival analysis and pathological features of advanced non-small cell lung cancer with miliary pulmonary metastases in patients harboring epidermal growth factor receptor mutations
    Yusuke Okuma
    Jumpei Kashima
    Kageaki Watanabe
    Sadamu Homma
    [J]. Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1601 - 1611
  • [32] Efficacy of Gefitinib for Elderly Patients with Advanced Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Gene Mutations: A Retrospective Analysis
    Uruga, Hironori
    Kishi, Kazuma
    Fujii, Takeshi
    Beika, Yuka
    Enomoto, Takahiro
    Takaya, Hisashi
    Miyamoto, Atsushi
    Morokawa, Nasa
    Kurosaki, Atsuko
    Yoshimura, Kunihiko
    [J]. INTERNAL MEDICINE, 2010, 49 (02) : 103 - 107
  • [33] Epidermal growth factor receptor somatic mutation analysis in 354 Chinese patients with non-small cell lung cancer
    Quan, Xueping
    Gao, Hongjun
    Wang, Zhikuan
    Li, Jie
    Zhao, Wentao
    Liang, Wei
    Yu, Qiang
    Guo, Dongliang
    Hao, Zhanping
    Liu, Jingxin
    [J]. ONCOLOGY LETTERS, 2018, 15 (02) : 2131 - 2138
  • [34] Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib
    Kanaoka, Kensuke
    Sumikawa, Hiromitsu
    Oyamada, Shunsuke
    Tamiya, Akihiro
    Inagaki, Yuji
    Taniguchi, Yoshihiko
    Nakao, Keiko
    Matsuda, Yoshinobu
    Okishio, Kyoichi
    [J]. BMC CANCER, 2023, 23 (01)
  • [35] Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors
    Jumpei Kashima
    Yusuke Okuma
    Maki Miwa
    Yukio Hosomi
    [J]. Medical Oncology, 2016, 33
  • [36] Osteoblastic bone reaction in non-small cell lung cancer harboring epidermal growth factor receptor mutation treated with osimertinib
    Kensuke Kanaoka
    Hiromitsu Sumikawa
    Shunsuke Oyamada
    Akihiro Tamiya
    Yuji Inagaki
    Yoshihiko Taniguchi
    Keiko Nakao
    Yoshinobu Matsuda
    Kyoichi Okishio
    [J]. BMC Cancer, 23
  • [37] Survival of patients with brain metastases from non-small cell lung cancer harboring EGFR mutations treated with epidermal growth factor receptor tyrosine kinase inhibitors
    Kashima, Jumpei
    Okuma, Yusuke
    Miwa, Maki
    Hosomi, Yukio
    [J]. MEDICAL ONCOLOGY, 2016, 33 (11)
  • [38] Dacomitinib for patients with non-small cell lung cancer harboring uncommon epidermal growth factor receptor mutations: Do mutation patterns matter?
    Li, Hong-Shuai
    Lei, Siyu
    Xu, Haiyan
    Xing, Puyuan
    Yan, Xiang
    Wang, Yan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Local Therapy for Oligoprogressive Disease in Advanced Staged Non-small Cell Lung Cancer Patients Harboring Epidermal Growth Factor Receptor Mutation
    Qiu, B.
    Liang, Y.
    Li, Q.
    Liu, G.
    Wang, F.
    Chen, Z.
    Liu, M.
    Zhao, M.
    Liu, H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E475 - E475
  • [40] Correlation between the qualification for bevacizumab use and the survival of patients with non-small cell lung cancer harboring the epidermal growth factor receptor mutation: a retrospective analysis
    Hakozaki, Taiki
    Okuma, Yusuke
    Hashimoto, Kana
    Hosomi, Yukio
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (10) : 2555 - 2564